slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 20,101-20,130
Pages 2,605
Rows per page 30
Component
20,101-20,130 of 78,129
16
The slide uses a combination of a process diagram (left) and statistical charts (right) to validate the 'naturalness' metric.Absci | Investor Presentation Deck | 26 slides · Absci
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
08
The central circular diagram represents a flywheel or iterative process.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
25
The slide uses box plots and bar charts to show statistical correlation between naturalness and clinical/developability outcomes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
26
The slide uses box plots and density plots to demonstrate that higher naturalness correlates with better expression and lower mutational burden.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
21
The slide uses a pie chart to show patient segmentation by B6 responsiveness and a timeline/number-line to show age of diagnosis, followed by key metrics on complication rates.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done2 hits
09
Clinical trial data showing efficacy of Odevixibat (Bylvay) vs Placebo.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · SolutionLoop · Before After2 hits
06
The slide uses a combination of a bar chart for preclinical data and a swimmer plot (timeline) for clinical patient outcomes.Aldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
12
Uses three distinct visual modules to present market data.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Problem2 hits
18
The slide uses a combination of a bar chart for historical growth, a donut chart for asset allocation, and a KPI table for business highlights.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution2 hits
24
The chart on the right uses a bell curve to visualize the target market segment.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
31
The slide highlights compliance with Nasdaq listing standards and specific governance policies.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations 2 hits
08
The bar chart shows growth from $457,965M to $502,191M. The pie chart shows the composition of the $502,191M total.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain2 hits
13
The slide uses two bar charts to contrast revenue growth against operating income performance.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 2 hits
14
The slide uses two bar charts to show financial performance trends.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 2 hits
15
TTM Net Sales figure provided at the bottom.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 2 hits
25
The slide uses two bar charts to show performance metrics against benchmarks.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction2 hits
32
The slide uses two bar charts side-by-side to demonstrate financial performance.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Loop · Quick Win Big Bet2 hits
08
The slide highlights the efficacy of VYVGART in achieving IWG-defined responses in ITP patients.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
14
The slide uses a split-layout with a dark sidebar for key facts and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
12
Data source: Zanos et al., 2016. The charts show dose-dependent reduction in immobility time.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
13
The slide uses a third-party study (Yang et al., 2015) to support the claim of a superior therapeutic index for R-ketamine.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
14
The slide contrasts the therapeutic benefit (MADRS) with the lack of side effects (CADSS) compared to S-Ketamine benchmarks.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
15
The slide notes that BAER-101 was previously known as AZD7325.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Product2 hits
16
The slide highlights the therapeutic window of BAER-101 by showing efficacy in the punished model without significant impairment in the un-punished model.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Product2 hits
23
The slide uses bar charts to demonstrate statistical significance (p < 0.001) of the drug over placebo in two different pain models.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 2 hits
11
Includes both GAAP and FTE (Fully Taxable-Equivalent) adjustments.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain2 hits
12
Includes footnotes regarding adjustments for litigation and regulatory expenses.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview2 hits
13
Includes a dual-axis chart for charge-offs and a waterfall-style bar chart for provisions.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview2 hits
14
Includes footnotes regarding loan definitions and exclusions.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview2 hits